accountAbbott Laboratories Inc said on Wednesday quarterly earnings jumped 28 percent on demand for its drugs, nutritional products and medical devices, including its new Xience stent used to prop open coronary arteries.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott profit jumps as drugs, devices shine
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account